Casas-Deza, D.; MartÃnez-Sapiña, A.; Espina, S.; Garcia-Rodriguez, B.; Fernandez-Bonilla, E.M.; Sanz-Paris, A.; Gonzalez-Irazabal, Y.; Bernal-Monterde, V.; Arbones-Mainar, J.M.
Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease. J. Clin. Med. 2022, 11, 4049.
https://doi.org/10.3390/jcm11144049
AMA Style
Casas-Deza D, MartÃnez-Sapiña A, Espina S, Garcia-Rodriguez B, Fernandez-Bonilla EM, Sanz-Paris A, Gonzalez-Irazabal Y, Bernal-Monterde V, Arbones-Mainar JM.
Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease. Journal of Clinical Medicine. 2022; 11(14):4049.
https://doi.org/10.3390/jcm11144049
Chicago/Turabian Style
Casas-Deza, Diego, Ana MartÃnez-Sapiña, Silvia Espina, Beatriz Garcia-Rodriguez, Eva M. Fernandez-Bonilla, Alejandro Sanz-Paris, Yolanda Gonzalez-Irazabal, Vanesa Bernal-Monterde, and Jose M. Arbones-Mainar.
2022. "Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease" Journal of Clinical Medicine 11, no. 14: 4049.
https://doi.org/10.3390/jcm11144049
APA Style
Casas-Deza, D., MartÃnez-Sapiña, A., Espina, S., Garcia-Rodriguez, B., Fernandez-Bonilla, E. M., Sanz-Paris, A., Gonzalez-Irazabal, Y., Bernal-Monterde, V., & Arbones-Mainar, J. M.
(2022). Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease. Journal of Clinical Medicine, 11(14), 4049.
https://doi.org/10.3390/jcm11144049